Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Bicycle_tx
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Bicycle_tx
-
We’re looking for a collaborative, passionate Translational Data Scientist to join our team based in Lexington, MA. Learn more about this opportunity to help discover cutting-edge therapies based on our unique Bicycle® technology: https://bit.ly/37Wnf5M pic.twitter.com/aoNg9DuZnL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re excited to partner with
@CR_UK to develop a new#ImmunoOncology therapeutic candidate, BT7401, a multivalent Bicycle® CD137 agonist and the latest addition to our portfolio of novel IO assets. Read about our collaboration in today’s press release: https://bit.ly/2ZZV5UA pic.twitter.com/UzoAwqgSmb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Bicycle team is growing! We’re seeking motivated and experienced candidates for open positions in the UK. Visit our website to learn about these exciting roles: https://www.bicycletherapeutics.com/careers/ pic.twitter.com/CKJPh2OSbI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re delighted to be a highly commended European IPO of the Year at the 2019
@LSXLeaders#LifestarsAwards! This distinction recognizes our pioneering IPO, which has allowed us to grow and advance an innovative pipeline based on our novel Bicycle® technology.pic.twitter.com/hMEFhfp1Uz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Powerful science doesn't just happen - it stems from powerful people. Our work to develop novel approaches for treating cancer and other difficult-to-treat diseases is
#PeoplePowered.pic.twitter.com/vyH6gzZ4W7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today, one of our Senior Scientists will present a poster at
#TIDESEUROPE on our novel, proprietary small molecule scaffolds, which we use to constrain Bicycles®, conferring many unique properties. Learn about the innovative structure of Bicycles®: https://bit.ly/2Q6TDwm pic.twitter.com/xzIpX7oedb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are excited to announce the initiation of a Phase I/II trial for BT5528, a Bicycle® Toxin Conjugate targeting the tumor antigen EphA2 and our first U.S. IND! Read more about this important step for Bicycle: https://bit.ly/2pe94ba pic.twitter.com/mk8YGfrtkb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re delighted to have been named Best Established Biotech at the 2019
@OBN_UK Awards, celebrating innovation and achievement in the life sciences industry. Thank you to the OBN judges for this recognition and to the Bicycle team for getting us to where we are today!pic.twitter.com/lytAzFAgV0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re at
#SITC2019 where our CSO, Nick Keen, Ph.D., will deliver an oral presentation on new preclinical data for BT7480, a potent tumor-targeted immune cell agonist and our lead#ImmunoOncology candidate. Find more details here: https://bit.ly/36F8rIz pic.twitter.com/wq0TR1SQj1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bicycle's proprietary and differentiated technology has the potential to impact a broad range of therapeutic areas beyond oncology. Learn more about how we’re exploring the possible far-reaching applicability of our novel platform here: http://bit.ly/2v70FVR
#PeoplePoweredpic.twitter.com/sRoKic83oJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bicycle is pleased to announce the appointment of Veronica Jordan, Ph.D., an accomplished life science business leader, to our Board of Directors. Read more in our press release: http://bit.ly/2ptlITU pic.twitter.com/f678AduKoy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bicycle welcomes Nigel Crockett, Ph.D., who joins the team as Chief Business Officer. Nigel has a proven track record in business development and brings to Bicycle over 25 years of industry experience. More details in today’s announcement: http://bit.ly/2ovCWzy pic.twitter.com/ddCbfUhItz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interested in joining a team of passionate, driven individuals working tirelessly to translate innovative, proprietary science into transformative medicines? Learn more about current openings at Bicycle: http://bit.ly/2VjZZrC
#biotechjobspic.twitter.com/6kZ8mgLmYL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bicycle's novel science is
#PeoplePowered by new ideas and continuous teamwork. Learn more about the Bicycle team and read perspectives from other current employees: http://bit.ly/2VjZZrC pic.twitter.com/GU8gvSRutx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’ve expanded our
#neuroscience collaboration with@TheDDFund to include Oxford's@ARUK_ODDI Learn more about this project to discover new therapies enabled by the differentiated properties of Bicycles® that could transform the treatment of dementia: /bit.ly/365AXD4pic.twitter.com/7uTb1Bpjc7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We look forward to presenting new translational data on BT1718 describing patient selection for our Phase IIa study & preclinical data from our other Bicycle® Toxin Conjugates at the AACR-NCI-EORTC 2019 meeting. Read more about our poster presentations: http://bit.ly/32jzJ4Q pic.twitter.com/XFC4rDVnCj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our CSO, Nick Keen, Ph.D., will be at
#WorldADC to deliver a keynote presentation on the power our Bicycle® Toxin Conjugates could have to solve therapeutic challenges unaddressed by other treatment modalities. Learn about our programs here: http://bit.ly/30P5fpv pic.twitter.com/0i5PjfC1xv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check out Bicycle’s feature in today’s
@statnews article on biotechs founded on#NobelPrize winning technology!https://twitter.com/statnews/status/1181132062893445120 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bicycle's Research and Development team is growing! View current US and UK openings here: http://bit.ly/2VjZZrC
#biotechjobspic.twitter.com/LunmfEPiCv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our VP of Chemistry, Kevin McDonnell, gave a talk on our most advanced Bicycle® Toxin Conjugate, BT1718, at the 2019 Boulder Peptide Symposium last week. Here he is discussing the potential our BTCs have to target solid tumors more effectively than existing modalities.pic.twitter.com/1s9SpdpfXy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.